B超引导下胸膜结核瘤内局部注药治疗临床分析  

Treatment for Pleura Tubercle Tumor with Pulmonary Paracentesis And Perfusing Chemotherapy Under B Ultrasound

作　　者：张琳琳[1] 于双全[2] 

机构地区：[1]山东省胸科医院,山东济南250013 [2]济南市第五人民医院,山东济南250013

出　　处：《临床肺科杂志》2012年第7期1293-1294,共2页Journal of Clinical Pulmonary Medicine

摘　　要：目的评价B超引导下胸膜结核瘤内局部注药治疗效果。方法选择我院胸膜结核瘤病例16例,给予B超引导下胸膜结核瘤内注药治疗,分别于治疗后1月、6月、12月观察治疗效果,对比病灶变化。结果观察1月末、6月末、12月末结核球变化。复查胸部CT,结核球平均直径明显减小,12月末10例完全吸收(62.5%),有或无胸膜增厚;2例病灶内钙化(12.5%);4例明显缩小(25%)。结论 B超引导下胸膜结核瘤内穿刺注药是治疗结核瘤安全和有效的方法,值得介绍。Objective To probe into a new treating method for Pleura tubercle tumor and evaluate the clinical efficacy for Pleura tubercle tumor with pulmonary paracentesis and perfusing chemotherapy under B ultrasound. Methods 16 patients with pleura tubercle tumor that treated by percutaneous pulmonary paracentesis under B ultrasound were selected. The treatment effects after 1 month, 6 months and 12 months were observed and compared. Results The average diameter of tuberculoma decreased after treatment. The lesions were completely absorbed in 10 cases at the end of 12 months （62.5%）, With or without pleural thickening; 2 cases of calcified lesions （ 12.5% ） ; The size of lesions significantly decreased in 4 cases （ 25% ）. Conclusion Pulmonary paracentesis and perfusing Chemotherapy under B Ultrasound is an effective menthod for treating pleura tubercle tumor. This method possesses the advantage of precise curative effect and leads to few complications. Therefore, it could be approached estensively in clinical practice.

关 键 词：B超引导 胸膜 结核瘤 穿刺注药 

分 类 号：R521.7[医药卫生—内科学]